Data Foundry

Medical device recalls 2021

Philips Azurion systems with software releases 2 — Class II medical device recall Z-0238-2022

Ongoing recall by Philips Healthcare, reported 2021-12-01, distributed nationwide. 3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product exten

Recall numberZ-0238-2022
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedFDA mandated
Recalling firmPhilips Healthcare, Andover, MA, United States
Recall initiated2021-09-24
Classified2021-11-24
Reported by FDA2021-12-01
DistributedNationwide (US)
Quantity226 units
Reason classessoftware

Product

Philips Azurion systems with software releases 2.1(L1) and 2.1(L2)

Reason for recall

3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product extends the functionality of compatible X-ray equipment with the capability of 3D X-ray imaging. Before starting a 3D-RA scan, the detector of the Philips Azurion system must be positioned in portrait or landscape orientation with an angle of 0 or +/-90 degrees relative to the 3D scan direction. Philips has discovered that Azurion releases 2.1(L1) and 2.1(L2) allow creation of a 3D-RA scan with a deviating detector orientation of up to 3 degrees from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees), relative to the 3D scan direction. 3D-RA scans with a deviating detector orientation of ore than 1.0 degree from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees) cannot be reconstructed with the 3D-RA reconstruction software.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0238-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.